Cytoplasmic staining of erbB-2 but not mRNA correlates with differentiation in human thyroid neoplasia

Clinical Endocrinology

Volumn 49, Issue 5, 1998, Pages 629-637

  Sugg, Sonia L ^a   Ezzat, Shereen ^a   Zheng, Lei ^a   Rosen, Irving B ^a   Freeman, Jeremy L ^a   Asa, Sylvia L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CYTOPLASM; DNA SEQUENCE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTO ONCOGENE; STAINING; THYROID CANCER;

CARCINOMA, PAPILLARY; CYTOPLASM; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, ERBB-2; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 0031768469     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00580.x     Document Type: Article

References (29)

1. Aasland, R., Lillehaug, J.R., Male, R., Jøsendal, O., Varhaug, J.E. & Kleppe, K. (1988) Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. British Journal of Cancer, 57, 358-363.
2. Akslen, L.A. & Varhaug, J.E. (1995) Oncoproteins and tumor progression in papillary thyroid. Cancer (Philadelphia), 76, 1643-1654.
3. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J.T., Dodge, R., Clarke-Pearson, D.L., Marks, P., McKenzie, S., Yin, S. & Bast, R.C. Jr. (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Research (Baltimore), 50, 4087-4091.
4. Busmanis, I., Feleppa, F., Jones, A., McGrath, K.M., Reed, R., Collins, J., Russell, I. & Begley, C.G. (1994) Analysis of cerbB2 expression using a panel of 6 commercially available antibodies. Pathology, 26, 261-267.
5. Corbett, I.P., Henry, J.A., Angus, B., Watchorn, C.J., Wilkinson, L., Hennessy, C., Gullick, W.J., Tuzi, N.L., May, F.E.B., Westley, B.R. & Horne, C.H.W. (1990) NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. Journal of Pathology, 161, 15-25.
6. De Potter, C.R., Quatacker, J., Maertens, G., Van Daele, S., Pauwels, C., Verhofstede, C., Eechaute, W. & Roels, H. (1989) The subcellular localization of the neu protein in human normal and neoplastic cells. International Journal of Cancer, 44, 969-974.
7. Evers, B.M., Rady, P.L., Sandoval, K., Arany, I., Tyring, S.K., Sanchez, R.L., Nealon, W.H., Townsend Jr, C.M. & Thomspon, J.C. (1994) Gastrinomas demonstrate amplification of the HER-2/neu protooncogene. Annals of Surgery, 219, 596-604.
8. Evers, B.M., Rády, P.L., Tyring, S.K., Sanchez, R.L., Rajaraman, S., Townsend, J.R., C.M. & Thompson, J.C. (1992) Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery (StLouis), 112, 211-218.
9. Ezzat, S., Zheng, L., Smyth, H.S. & Asa, S.L. (1997) The c-erbB-2/neu proto-oncogene in human pituitary tumours. Clinical Endocrinology (Oxford), 46, 599-606.
10. Frye, R.A., Benz, C.C. & Liu, E. (1989) Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene (Basingstoke), 4, 1153-1157.
11. Hall, P.A., Hughes, C.M., Staddon, S.L., Richman, P.I., Gullick, W.J. & Lemoine, N.R. (1990) The c-erbB-2 proto-oncogene in human pancreatic cancer. Journal of Pathology, 161, 195-200.
12. Haugen, D.R.F., Akslen, L.A., Varhaug, J.E. & Lillehaug, J.R. (1992) Expression of c-erbB-2 protein in papillary thyroid carcinomas. British Journal of Cancer, 65, 832-837.
13. ERBB2 expression and gene amplification. Cancer Research (Baltimore), 50, 8002-8009.
14. Lemoine, N.R., Staddon, S., Dickson, C., Barnes, D.M. & Gullick, W.J. (1990a) Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene (Basingstoke), 5, 237-239.
15. Lemoine, N.R., Wyllie, F.S., Lillehaug, J.R., Staddon, S.L., Hughes, C.M., Aasland, R., Shaw, J., Varhaug, J.E., Brown, C.L., Gullick, W.J. & Wynford-Thomas, D. (1990b) Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia. European Journal of Cancer, 26, 777-779.
16. Liu, E., Thor, A., He, M., Barcos, M., Ljung, B.M. & Benz, C.C. (1992) Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene (Basingstoke), 7, 1027-1032.
17. LiVolsi, V.A. (1990) Surgical Pathology of the Thyroid. W.B. Saunders Company, Philadelphia.
18. Murray, D. (1991) The thyroid gland. In Functional Endocrine Pathology (eds K. Kovacs & S.L. Asa), pp. 293-374. Blackwell Scientific Publications, Inc., Boston.
19. Ness, G.O., Haugen, D.R.F., Varhaug, J.E., Akslen, L.A. & Lillehaug, J.R. (1996) Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas: association with the 150-kDa receptor form. International Journal of Cancer, 65, 161-167.
20. Sauter, G., Moch, M., Moore, D., Carroll, P., Kerschmann, R., Chew, K., Mihatsch, M.J., Gudat, F. & Waldman, F. (1993) Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Research (Baltimore), 53, 2199-2203.
21. Scott, G.K., Dodson, J.M., Montgomery, P.A., Johnson, R.M., Sarup, J.C., Wong, W.L., Ullrich, A., Shepard, H.M. & Benz, C.C. (1991) p185HER2 signal transduction in breast cancer cells. Journal of Biological Chemistry, 266, 14300-14305.
22. Segatto, O., King, C.R., Pierce, J.H., Di Fiore, P.P. & Aaronson, S.A. (1988) Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Molecular and Cellular Biology, 8, 5570-5574.
23. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. & McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
24. Soares, P., Sambade, C. & Sobrinho-Simoes, M. (1994) Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid. International Journal of Cancer, 56, 459-461.
25. Stern, D.F., Kamps, M.P. & Cao, H. (1988) Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Molecular and Cellular Biology, 8, 3969-3973.
26. 659). Embo Journal, 9, 181-190.
27. Sugg, S.L., Zheng, L., Rosen, I.B., Freeman, J.L., Ezzat, S. & Asa, S.L. (1996) ret/PTC-1, -2 and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? Journal of Clinical Endocrinology and Metabolism (Baltimore), 81, 3360-3365.
28. Valerón, P.F., Chirino, R., Fernandez, L., Torres, S., Navarro, D., Aguiar, J., Cabrera, J.J., Diaz-Chico, B.N. & Diaz-Chico, J.C. (1996) Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer. International Journal of Cancer, 65, 129-133.
29. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V. & Greene, M.I. (1989) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (London), 339, 230-231.